XML 58 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Tables)
12 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment financial information
    As of June 30,  
    2020     2019  
 Consolidated revenue:            
 Aytu BioScience   $ 17,249,000     $ 7,320,000  
 Aytu Consumer Health     10,383,000       -  
 Consolidated revenue   27,632,000     7,320,000  
                 
                 
 Consolidated net loss:                
 Aytu BioScience   (10,464,000 )   (27,132,000 )
 Aytu Consumer Health     (3,157,000 )     -  
 Consolidated net loss   (13,621,000 )   (27,132,000 )
                 
                 
 Total assets:                
 Aytu BioScience   $ 126,267,000     $ 34,721,000  
 Aytu Consumer Health     26,569,000       -  
 Total assets   $ 152,836,000     $ 34,721,000  

 

    As of June 30,  
    2020     2019  
Goodwill            
Aytu BioScience   $ 19,453,000      
Aytu Consumer Health     8,637,000        
Consolidated Goodwill   $ 28,090,000